James McGill Professor and Chairman, Department of Oncology, and Director, Division of Cancer Epidemiology, McGill University
Dr. Franco trained in public health at University of North Carolina and at the CDC, and as a cancer epidemiologist at NIH, IARC, and Louisiana State University. Since 1985, his research has focused on the epidemiology and prevention of gynecologic, anogenital, oral, prostate, and childhood cancers, topics on which he published 465 articles (Scopus h-index=76) and two books. He is mostly known for his contributions to our understanding of HPV infection as the cause of cervical cancer and to preventing this disease via vaccination and improved screening strategies. He received the Canadian Cancer Research Alliance’s Distinguished Service to Cancer Research Award, Lifetime Achievement Awards from the American Society for Colposcopy and Cervical Pathology and from the International Papillomavirus Society, the Women in US Government’s Leadership Award, the Canadian Cancer Society’s Warwick Prize, the Geoffrey Howe Outstanding Contribution Award from the Canadian Society for Epidemiology and Biostatistics, University of British Columbia’s Chew Wei Memorial Prize in Cancer Research, and the McLaughlin-Gallie Award from the Royal College of Physicians of Canada. He is the Editor-in-Chief of Preventive Medicine, Officer of the Order of Canada, and Fellow of the Royal Society of Canada and of the Canadian Academy of Health Sciences.
Department of Physiology
Dr. Russell (Rusty) Jones is an Associate Professor in the Department of Physiology and Goodman Cancer Research Centre at McGill University. Dr. Jones received his Ph.D. in Medical Biophysics in 2003 from the University of Toronto, and completed post-doctoral training with Dr. Craig Thompson at the University of Pennsylvania. His research focuses on investigating the genetic and biochemical pathways that control metabolic reprogramming in cancer and the immune system. One goal of Dr. Jones’ research is to investigate how cellular metabolism can be used to target the metabolic vulnerabilities of cancer cells, and how we can enhance immune responses to cancer through metabolic interventions. Dr. Jones is a William Dawson Scholar of McGill University and the recipient of the Dorval Young Investigator Prize from the Canadian Cancer Society. His work is supported by Canadian Institutes of Health research (CIHR), The Canadian Cancer Society, The Terry Fox Foundation, The Cancer Research Society, and The Canadian Foundation for Innovation. Dr. Jones also acts an independent consultant for cancer metabolism and immunology for pharmaceutical and biotechnology companies worldwide.